Solid Biosciences Inc (NASDAQ:SLDB)
| 2.74 Delayed Data As of Sep 21 |  0.00 / 0.00%Today’s Change | 2.71 Today|||52-Week Range 8.85 | -49.07% Year-to-Date |
Latest SLDB News | Press Releases
No recent news for Solid Biosciences Inc.
Today’s Trading
| Previous close | 2.74 |
| Today’s open | 2.73 |
| Day’s range | 2.73 - 2.74 |
| Volume | 36 |
| Average volume (3 months) | 19,373 |
| Market cap | $61.5M |
Data as of 3:23pm ET, 09/21/2023
Growth & Valuation
| Earnings growth (last year) | +0.40% |
| Earnings growth (this year) | +43.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -40.57% |
| P/E ratio | NM |
| Price/Sales | 5.66 |
| Price/Book | 0.28 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OTLKOutlook Therapeutics... | +0.00 | +0.57% |
| DYAIDyadic International... | 0.00 | 0.00% |
| PSNLPersonalis Inc | -0.04 | -2.71% |
| CRISCuris Inc | -0.00 | -0.53% |
Data as of 3:59pm ET, 09/22/2023
Financials
| Next reporting date | November 9, 2023 |
| EPS forecast (this quarter) | -$1.48 |
| Annual revenue (last year) | $8.1M |
| Annual profit (last year) | -$86.0M |
| Net profit margin | -1,062.28% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Charlestown, Massachusetts |
Forecasts
